Oxford BioDynamics (LON:OBD) Trading Down 11.6% – Here’s Why

Oxford BioDynamics Plc (LON:OBD) fell 11.6% during mid-day trading on Wednesday . The stock traded as low as GBX 0.94 ($0.01) and last traded at GBX 0.97 ($0.01). 4,693,215 shares were traded during mid-day trading, an increase of 14% from the average session volume of 4,110,961 shares. The stock had previously closed at GBX 1.10 ($0.01).

Oxford BioDynamics Stock Performance

The company has a quick ratio of 2.80, a current ratio of 0.68 and a debt-to-equity ratio of 370.22. The company has a market cap of £3.01 million, a PE ratio of -16.07 and a beta of 0.42. The firm has a fifty day simple moving average of GBX 1.26 and a 200-day simple moving average of GBX 3.99.

Insider Activity

In related news, insider David Holbrook purchased 49,653 shares of the company’s stock in a transaction that occurred on Monday, October 28th. The shares were purchased at an average price of GBX 1 ($0.01) per share, for a total transaction of £496.53 ($619.42). Corporate insiders own 16.78% of the company’s stock.

Oxford BioDynamics Company Profile

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients.